While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too. Nov 2, 2009 By:Michelle Hoffman
While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too.
 |
 | A Conversation with Greystone Associates' George Perros. This article contains bonus online-exclusive material. Nov 1, 2009 By:Michelle Hoffman
A Conversation with Greystone Associates' George Perros. This article contains bonus online-exclusive material.
 |
 | A Conversation with Otonomy Nov 1, 2009 By:Michelle Hoffman
A Conversation with Otonomy
 |
After years of promomting QbD concepts, FDA's ready to take action on nonconformers. Sep 2, 2009 By:Michelle Hoffman
After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
 |
 | View the corporate lineages of pharma's top companies. Aug 2, 2009 By:Michelle Hoffman
View the corporate lineages of pharma's top companies.
 |
Individuals and companies at the top seem to have no problem short-circuiting their success. Aug 2, 2009 By:Michelle Hoffman
Individuals and companies at the top seem to have no problem short-circuiting their success.
 |
As the pharmaceutical supply chain expands, sponsor companies need to weigh all their options. Aug 1, 2009 By:Michelle Hoffman
As the pharmaceutical supply chain expands, sponsor companies need to weigh all their options.
 |
Is it good policy to pay for bad behavior? Jul 2, 2009 By:Michelle Hoffman
Is it good policy to pay for bad behavior?
 |
A Pharmaceutical Technology report looks at trends in biopharmaceutical manufacturing. This article contains bonus online-exclusive material. Jul 2, 2009 By: Michelle Hoffman
A Pharmaceutical Technology report looks at trends in biopharmaceutical manufacturing. This article contains bonus online-exclusive material.
 |
|